Trading mostly below its five-year forward averages; together with an attractive yield; IFM's latest share grab has been labeled opportunistic. That sounds like a BUY here.
What is covered in the Full Insight:
Atlas Arteria's Rejected Proposal
IFM's Involvement and share Growth
Board Representation and Share Value
Potential Future Moves
Insight into Recent Performance
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.